330 related articles for article (PubMed ID: 15750686)
21. Fracture risk reduction during treatment with teriparatide is independent of pretreatment bone turnover.
Delmas PD; Licata AA; Reginster JY; Crans GG; Chen P; Misurski DA; Wagman RB; Mitlak BH
Bone; 2006 Aug; 39(2):237-43. PubMed ID: 16563890
[TBL] [Abstract][Full Text] [Related]
22. [Treatment and management of severe osteoporosis].
Okano T; Hagino H
Clin Calcium; 2006 Sep; 16(9):1451-56. PubMed ID: 16951467
[TBL] [Abstract][Full Text] [Related]
23. [Guideline for adequate use of metabolic bone markers in osteoporosis].
Nishizawa Y; Nakatsuka K
Nihon Rinsho; 2004 Feb; 62 Suppl 2():325-32. PubMed ID: 15035146
[No Abstract] [Full Text] [Related]
24. [N-terminal crosslinking telopeptide of type I collagen].
Fukunaga M
Nihon Rinsho; 2004 Dec; 62 Suppl 12():236-9. PubMed ID: 15658308
[No Abstract] [Full Text] [Related]
25. [Serum beta-CTx(beta-CrossLaps)].
Okabe R
Nihon Rinsho; 2004 Feb; 62 Suppl 2():369-72. PubMed ID: 15035154
[No Abstract] [Full Text] [Related]
26. [Biochemical basis of bone resorption markers].
Ichimura S; Iwamoto J
Nihon Rinsho; 2002 Mar; 60 Suppl 3():228-35. PubMed ID: 11979912
[No Abstract] [Full Text] [Related]
27. [Absolute risk for fracture and WHO guideline. Bone turnover markers as predictive factors for osteoporotic fractures].
Yoshimura N;
Clin Calcium; 2007 Jul; 17(7):1049-57. PubMed ID: 17607072
[TBL] [Abstract][Full Text] [Related]
28. [Osteoporosis in patients with diabetes mellitus].
Yamauchi M
Nihon Rinsho; 2007 Nov; 65 Suppl 9():526-30. PubMed ID: 18161160
[No Abstract] [Full Text] [Related]
29. [Cross-linked N-telopeptides of type I collagen(NTX)].
Saito S; Nakatsuka K
Nihon Rinsho; 2004 Feb; 62 Suppl 2():358-62. PubMed ID: 15035152
[No Abstract] [Full Text] [Related]
30. [Can biochemical markers for bone density be recommended as diagnostic and prognostic tools in osteoporosis?].
Midtby M; Magnus JH
Tidsskr Nor Laegeforen; 1998 Feb; 118(4):575-9. PubMed ID: 9520586
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation methods of therapeutic effects of drugs for osteoporosis].
Ishibashi H
Clin Calcium; 2012 Jun; 22(6):890-5. PubMed ID: 22653030
[TBL] [Abstract][Full Text] [Related]
32. The use of biochemical markers in osteoporosis.
Hammett-Stabler CA
Clin Lab Med; 2004 Mar; 24(1):175-97. PubMed ID: 15157562
[TBL] [Abstract][Full Text] [Related]
33. [New development in bisphosphonate treatment. Review of effect on bone metabolism by minodronic acid in primary osteoporosis].
Fukunaga M
Clin Calcium; 2009 Jan; 19(1):63-73. PubMed ID: 19122266
[TBL] [Abstract][Full Text] [Related]
34. Systemic assessments utilizing saliva: part 2 osteoporosis and use of saliva to measure bone turnover.
Koka S; Forde MD; Khosla S
Int J Prosthodont; 2006; 19(1):53-60. PubMed ID: 16479761
[TBL] [Abstract][Full Text] [Related]
35. Markers of bone metabolism in eugonadal female patients with beta-thalassemia major.
Angelopoulos NG; Goula A; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Konstandelou E; Tolis G
Pediatr Hematol Oncol; 2007; 24(7):481-91. PubMed ID: 17786784
[TBL] [Abstract][Full Text] [Related]
36. [New biochemical markers of bone turnover].
Okabe R; Ueda M
Nihon Rinsho; 2002 Mar; 60 Suppl 3():249-55. PubMed ID: 11979915
[No Abstract] [Full Text] [Related]
37. Potential use of biochemical markers of bone turnover for assessing the effect of calcium supplementation and predicting fracture risk.
Weisman SM; Matkovic V
Clin Ther; 2005 Mar; 27(3):299-308. PubMed ID: 15878383
[TBL] [Abstract][Full Text] [Related]
38. Osteoporosis and prevention of fractures: practical approaches for orthopaedic surgeons.
Kaufman JD; Cummings SR
Instr Course Lect; 2002; 51():559-65. PubMed ID: 12064147
[No Abstract] [Full Text] [Related]
39. Clinical use of serum and urine bone markers in the management of osteoporosis.
Srivastava AK; Vliet EL; Lewiecki EM; Maricic M; Abdelmalek A; Gluck O; Baylink DJ
Curr Med Res Opin; 2005 Jul; 21(7):1015-26. PubMed ID: 16004668
[TBL] [Abstract][Full Text] [Related]
40. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
